ABSTRACT
As serpentes peçonhentas dos gêneros Bothrops e Crotalus têm sido mantidas em cativeiro visando à extração de venenos para a produção de imunobiológicos. O conhecimento da fisiologia desses animais e as alterações na concentração de proteínas e suas frações séricas são importantes para a identificação precoce de importantes enfermidades que cursam com estados de hipoproteinemia e hiperproteinemia. O objetivo do trabalho foi determinar a concentração de proteína total e o perfil eletroforético das proteínas séricas de serpentes Crotalus durissus terrificus (cascavel) criadas em cativeiro. Foram colhidas amostras de sangue da veia coccígea ventral de 21 serpentes adultas e sadias, divididas em dois grupos: Grupo 1 de 12 machos com peso médio de 588,89±193,55g, e Grupo 2 de nove fêmeas com peso médio de 708,33±194,04g. A proteína total sérica foi determinada pelo método de refratometria e a eletroforese em gel de agarose. Obtiveram-se valores da proteína total sérica (g/dL) de 4,51±0,50 para machos e de 4,82±0,72 para fêmeas, e para machos e fêmeas de 4,64±0,61. Foram identificadas pela eletroforese quatro frações protéicas (g/dL): albumina, a, b, g-globulinas e calculada a relação albumina:globulina. As serpentes fêmeas apresentaram maiores valores para as variáveis, albumina e para a relação albumina/globulina (AG) diferindo significativamente (P<0,05) do grupo de machos, porém sem significado clínico.
The poisonous snakes of the genera Crotalus and Bothrops have been kept in captivity with the purpose of extracting poison for the production of immunobiological. Knowledge of the physiology of these animals and serum proteins concentration changes are important for early identification of major diseases which lead to states of hypoproteinemia and hyperproteinemia. The objective was to determine the concentration of total protein and serum protein electrophoresis profile of Crotalus durissus terrificus (rattlesnake) in captivity. Blood samples were taken from the ventral coccygeal vein of 21 adult and healthy snakes divided into groups: Group 1 with 12 males, weighing in average 588.89±193.55g, and Group 2 with nine females, weighing in average 708.33±194.04g. The total serum concentration of protein was determined by the method of refractometry and agarose gel electrophoresis. The total protein values in the serum for females was 4.82±0.72, for males 4.51±0.50 and males and females 4.64±0.61, identified by four fractions (g/dL): albumin, a, b and g-globulin. Additionally the albumin/globulin ratio was calculated. The female snakes showed higher values for the variables, albumin and the albumin/globulin (AG) differed significantly (P<0.05) from the group of male snakes, but there was no clinical significance.
Subject(s)
Animals , Male , Female , Albumins , Alpha-Globulins , Beta-Globulins , Crotalus , gamma-Globulins , Refractometry/methods , Blood Protein Electrophoresis/methods , Electrophoresis, Agar Gel/methodsABSTRACT
La probabilidad de evolucionar a hepatopatía crónica posterior a una infección por el virus B depende de la edad el 80 al 90% de los niños expuestos el primer año de vida desarrollarán la enfermedad. Se debe incluir la serología para el virus B en los exámenes de rutina del control prenatal. La inmunoprofilaxis pasiva y activa previene la infección perinatal del virus B. En las mujeres embarazadas portadoras de infección crónica por virus B con alta carga viral se documenta un 20-30% de transmisión al niño recién nacido. Las madres con alta carga viral deben ser tratadas con lamiduvina posterior a la semana 28 de gestación. El niño de madre con alta carga viral debe recibir dos dosis de HBIg y el esquema de vacunación. El niño de madre positiva con carga viral baja debe recibir dosis única de HBIg y esquema de vacunación completa. Se debe de realizar control serológico de anticuerpo y antígeno de superficie en el niño entre los 9 -15 meses de edad. La lactancia no está contraindicada.
The probability to evolve to chronic liver disease post HBV infection depends on the age. Between 80 to 90% of children exposed in their first year of life will develop this disease.The serology for HBV must be included in the routine tests of perinatal control. The active and passive immunoprophylaxis prevents the perinatal infection of HBV. It has been documented that pregnant women carrying the HBV chronic infection with high viral burden have a 2030% transmission to the new born child. Those mothers with high viral burden must be treated with lamiduvine after the 28th gestation week. The child of a mother with high viral burden must receive two unique dosages of HBIg and a complete vaccination scheme. Antibody and surface antigen serologic control must be done to the child between 9-15 months of age. Lactancy is not contraindicated.